Home NDC 61245-620-13 Direct Safety Aspirin
Product NDC 61245-620
Requested package NDC 61245-620-13
11-digit product format 612450620
Labeler code 61245
Product ID 61245-620_da42281b-38e4-6d4c-e053-2995a90a65b1
Type HUMAN OTC DRUG
Nonproprietary name Aspirin
Dosage form TABLET, COATED
Route ORAL
Labeler Direct Safety
Application part343
Marketing category OTC MONOGRAPH NOT FINAL
Marketing start 2021-02-15
Marketing end 0000-00-00
Substance ASPIRIN
Active strength 325 mg/1
Pharmacologic classes Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]
NDC exclude flag No
Listing certified through 2023-12-31
Current FDA listing Historical FDA.report record Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 12 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Snapshot, Source SHA-256 table Captured / source date Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 f5e01cc5f278…a2eaf40c39c3…2025-04-01 02:39 UTC · source 2025-03-31 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 0efc9e666f02…f202fb6c5f17…2024-11-09 02:27 UTC · source 2024-11-08 ad56d346431e…cc804d4bbf1e…2024-10-04 04:10 UTC · source 2024-10-03 367a005e9d99…383a685ebd0f…2024-07-10 04:00 UTC · source 2024-07-09 557ba5c1ecfa…9c80585c8c6e…
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed Product Concepts# FDA-Initiated Inactive NDC Indexing# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 61245-620-13 Direct Safety Aspirin 2 in 1 PACKET TABLET, COATED 2 7 61245-620-13 Direct Safety Aspirin 250 in 1 BOX TABLET, COATED 250 7
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 61245-620 DIRECT SAFETY ASPIRIN (ASPIRIN) TABLET, COATED DIRECT SAFETY ASPIRIN (ASPIRIN) TABLET, FILM COATED [DIRECT SAFETY] 6 Legacy NDC, 2 package rows 20241030_ba9ba697-d3df-49d7-e053-2a95a90af406.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 61245-620-13 61245062013 250 PACKET in 1 BOX (61245-620-13) > 2 TABLET, COATED in 1 PACKET 250 packet 2021-02-15 0000-00-00 No No Current